BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20961664)

  • 1. Antemortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies.
    Kantarci K; Yang C; Schneider JA; Senjem ML; Reyes DA; Lowe VJ; Barnes LL; Aggarwal NT; Bennett DA; Smith GE; Petersen RC; Jack CR; Boeve BF
    Neurobiol Aging; 2012 May; 33(5):878-85. PubMed ID: 20961664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
    Gomperts SN; Locascio JJ; Makaretz SJ; Schultz A; Caso C; Vasdev N; Sperling R; Growdon JH; Dickerson BC; Johnson K
    JAMA Neurol; 2016 Nov; 73(11):1334-1341. PubMed ID: 27654968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.
    Fodero-Tavoletti MT; Smith DP; McLean CA; Adlard PA; Barnham KJ; Foster LE; Leone L; Perez K; Cortés M; Culvenor JG; Li QX; Laughton KM; Rowe CC; Masters CL; Cappai R; Villemagne VL
    J Neurosci; 2007 Sep; 27(39):10365-71. PubMed ID: 17898208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease.
    Shirvan J; Clement N; Ye R; Katz S; Schultz A; Johnson KA; Gomez-Isla T; Frosch M; Growdon JH; Gomperts SN
    Neurology; 2019 Jul; 93(5):e476-e484. PubMed ID: 31243072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia.
    Burack MA; Hartlein J; Flores HP; Taylor-Reinwald L; Perlmutter JS; Cairns NJ
    Neurology; 2010 Jan; 74(1):77-84. PubMed ID: 20038776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
    Ikonomovic MD; Klunk WE; Abrahamson EE; Mathis CA; Price JC; Tsopelas ND; Lopresti BJ; Ziolko S; Bi W; Paljug WR; Debnath ML; Hope CE; Isanski BA; Hamilton RL; DeKosky ST
    Brain; 2008 Jun; 131(Pt 6):1630-45. PubMed ID: 18339640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Amyloid PET and neuropathology in dementia with Lewy bodies.
    Kantarci K; Lowe VJ; Chen Q; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Graff-Radford J; Jones DT; Knopman DS; Graff-Radford N; Ferman TJ; Parisi JE; Dickson DW; Petersen RC; Boeve BF; Murray ME
    Neurology; 2020 Jan; 94(3):e282-e291. PubMed ID: 31862783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging beta-amyloid burden in aging and dementia.
    Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
    Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.
    Bacskai BJ; Frosch MP; Freeman SH; Raymond SB; Augustinack JC; Johnson KA; Irizarry MC; Klunk WE; Mathis CA; Dekosky ST; Greenberg SM; Hyman BT; Growdon JH
    Arch Neurol; 2007 Mar; 64(3):431-4. PubMed ID: 17353389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging amyloid deposition in Lewy body diseases.
    Gomperts SN; Rentz DM; Moran E; Becker JA; Locascio JJ; Klunk WE; Mathis CA; Elmaleh DR; Shoup T; Fischman AJ; Hyman BT; Growdon JH; Johnson KA
    Neurology; 2008 Sep; 71(12):903-10. PubMed ID: 18794492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid imaging of Lewy body-associated disorders.
    Foster ER; Campbell MC; Burack MA; Hartlein J; Flores HP; Cairns NJ; Hershey T; Perlmutter JS
    Mov Disord; 2010 Nov; 25(15):2516-23. PubMed ID: 20922808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies.
    Diaz-Galvan P; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Min HP; Jain M; Miyagawa T; Forsberg LK; Fields JA; Savica R; Graff-Radford J; Jones DT; Botha H; St Louis EK; Knopman DS; Ramanan VK; Ross O; Graff-Radford N; Day GS; Dickson DW; Ferman TJ; Petersen RC; Lowe VJ; Boeve BF; Kantarci K
    Neurology; 2023 Jul; 101(2):e178-e188. PubMed ID: 37202168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
    Kantarci K; Lowe VJ; Boeve BF; Senjem ML; Tosakulwong N; Lesnick TG; Spychalla AJ; Gunter JL; Fields JA; Graff-Radford J; Ferman TJ; Jones DT; Murray ME; Knopman DS; Jack CR; Petersen RC
    Ann Neurol; 2017 Jan; 81(1):58-67. PubMed ID: 27863444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia.
    Nedelska Z; Schwarz CG; Lesnick TG; Boeve BF; Przybelski SA; Lowe VJ; Kremers WK; Gunter JL; Senjem ML; Graff-Radford J; Ferman TJ; Fields JA; Knopman DS; Petersen RC; Jack CR; Kantarci K
    JAMA Netw Open; 2019 Dec; 2(12):e1916439. PubMed ID: 31790563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain amyloid and cognition in Lewy body diseases.
    Gomperts SN; Locascio JJ; Marquie M; Santarlasci AL; Rentz DM; Maye J; Johnson KA; Growdon JH
    Mov Disord; 2012 Jul; 27(8):965-73. PubMed ID: 22693110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.
    Edison P; Rowe CC; Rinne JO; Ng S; Ahmed I; Kemppainen N; Villemagne VL; O'Keefe G; Någren K; Chaudhury KR; Masters CL; Brooks DJ
    J Neurol Neurosurg Psychiatry; 2008 Dec; 79(12):1331-8. PubMed ID: 18653550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.
    Bourgeat P; Chételat G; Villemagne VL; Fripp J; Raniga P; Pike K; Acosta O; Szoeke C; Ourselin S; Ames D; Ellis KA; Martins RN; Masters CL; Rowe CC; Salvado O;
    Neurology; 2010 Jan; 74(2):121-7. PubMed ID: 20065247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of Pittsburgh compound-B-negative dementia.
    Takeuchi J; Shimada H; Ataka S; Kawabe J; Mori H; Mizuno K; Wada Y; Shiomi S; Watanabe Y; Miki T
    Dement Geriatr Cogn Disord; 2012; 34(2):112-20. PubMed ID: 22947919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
    Gupta HV; Beach TG; Mehta SH; Shill HA; Driver-Dunckley E; Sabbagh MN; Belden CM; Liebsack C; Dugger BN; Serrano GE; Sue LI; Siderowf A; Pontecorvo MJ; Mintun MA; Joshi AD; Adler CH
    J Alzheimers Dis; 2021; 80(4):1603-1612. PubMed ID: 33720879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy.
    Claassen DO; Lowe VJ; Peller PJ; Petersen RC; Josephs KA
    Parkinsonism Relat Disord; 2011 Mar; 17(3):160-5. PubMed ID: 21195652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.